Ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC–MS/MS) was used by researchers from Murray State University, Kentucky, USA to analyze isoprostanes in wastewater to assess oxidative stress changes of human populations during the COVID-19 pandemic (1).
Globally, the COVID-19 pandemic has had a devastating impact on communities, with bereavement, isolation, loss of income, and fear triggering innumerable mental health conditions and exacerbating existing ones (2). This psychological stress results in elevated levels of reactive oxygen species (ROS), which in turn catalyzes the oxidation of arachidonic acid and releases isoprostanes, such as the F2-isoprostanes. The ROS-catalyzed oxidization of cellular constituents can eventually result in oxidative damage to DNA and the wide array of complications from such damage.
The impact of COVID-19, in terms of oxidative stress on communities, can be measured using raw wastewater as a pooled urine sample for communities, as excreted isoprostanes are typically flushed down the drain and reach the respective centralized wastewater treatment plants. Importantly, four isoprostanes (8-iso-PGF2a, 2,3-dinor-iPF2a-III, PGE2, and 5-iPF2a-VI) have previously shown to be resistant to degradation under typical sewer conditions and would therefore be ideal subjects for analysis.
As such, researchers developed and validated a UHPLC–MS/MS method capable of determining the presence of the four isoprostanes in wastewater. The target isoprostanes were monitored in one community in western Kentucky (USA) and one community in western Tennessee (USA) for ten consecutive days in typical weeks every month, starting from March 27th to July 1st, 2020. This sampling period covers the first four months of the COVID-19 outbreak in the US, including events such as the closure of schools, public gatherings, and non-life-sustaining business in March, the civil unrest, and the conditional reopening of select businesses and public gatherings in May.
The results consistently detected PGE2 and 5-iPF2a-VI in wastewater suggesting that PGE2 and 5-iPF2a-VI can be a reliable biomarker of community oxidative anxiety. The study attributed higher than expected four-month averages of isoprostanes to the stress and anxiety induced by COVID-19. PGE2 and 5-iPF2a-VI mass loads were significantly increased from the first month of the study to the second, however, they significantly decreased in the third. Researchers believed that wastewater-based-epidemiological determination of isoprostanes can be a near-real-time and cost-effective approach to determining trends in community depression.
References
1) I. Bowers and B. Subedi, Chemosphere 271, 129489 (2021).
2) WHO World Health Organization, 2020. COVID-19 Disrupting Mental Health Services in Most Countries. WHO survey. https://www.who.int/news/item/05-10-2020-covid-19-disrupting-mental-health-services-in-most-countries-whosurvey.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.